Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple mineral test predict ventilator needs in sepsis?

NCT ID NCT07739251

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study investigates whether low blood phosphate levels in patients with sepsis are linked to how long they need mechanical ventilation. Sepsis is a life-threatening condition where the body's response to infection damages its own organs, often requiring breathing support. The researchers will measure phosphate levels in 110 adult sepsis patients upon ICU admission and track the duration of their ventilator use, aiming to see if a simple blood test could help predict outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If a link is found, it could point to early phosphate monitoring as a way to identify high-risk sepsis patients and potentially shorten their time on a ventilator.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The results may not apply to all sepsis patients, and other factors could influence the outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with sepsis or meeting the diagnostic criteria of septic shock

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with sepsis or meeting the diagnostic criteria of septic shock * Clinical criteria of septic shock * A patient with sepsis who, despite adequate fluid resuscitation, has: * A vasopressor requirement to maintain a mean arterial pressure (MAP) ≥ 65 mmHg, and * A serum lactate level \> 2 mmol/L (18 mg/dL) * Age more than 18 years old Exclusion Criteria: * \- Age less than 18 years. * ICU stay less than 24 hours. * Patients receiving renal replacement therapy before ICU admission. * Patients with known parathyroid disorders or metabolic bone disease. * Patients receiving phosphate supplements before ICU admission. * Patients receiving medications affecting phosphate levels, such as , insulin overdose, or chemotherapy. * Patients with diabetic ketoacidosis. * Patients with burns, major trauma, or postoperative ICU admission. * Pregnant patients. * Refusal to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sepsis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sepsis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.